Marcio Souza
CIK 1707657 · Chief Executive Officer · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$25.54M
Companies
3
Total Filings
41
Lifetime Open-Market Net
-$5.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Chief Executive Officer | 79,616 | $266.58 | $21.22M | $371.8K | 27 | 2026-05-19 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | 90,000 | $12.01 | $1.08M | $50.5K | 3 | 2022-08-25 |
| PTCT | Chief Operating Officer | 57,466 | $75.14 | $4.32M | -$5.48M | 11 | 2020-02-12 |
Recent Filings · Page 5 of 5
41 filingsForm 4 transactions across all companies, newest first.
Showing 41–41 of 41
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.